139. Comparison of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockade for the Prevention of Premalignant Changes in the Liver
139. Comparison of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockade for the Prevention of Premalignant Changes in the Liver